Methylated DNA immunoprecipitation

Journal of Visualized Experiments

Volumn , Issue 23, 2009, Pages

  Thu, Kelsie L ^a,b   Vucic, Emily A ^a,b   Kennett, Jennifer Y ^a,b   Heryet, Cameron ^c   Brown, Carolyn J ^b   Lam, Wan L ^a,b   Wilson, Ian M ^a,b  

^a BC Cancer Research Centre   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

5 methylcytosine antibody; Anti 5 methylcytosine; Cell biology; DNA methylation; Epigenetics; Epigenomics; Immunoprecipitation; Issue 23; MeDip protocol; Methylcytosine; Microarray

Indexed keywords

EID: 80055112974     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/935     Document Type: Article

References (14)

1. Beck, S. & Rakyan, V.K. The methylome: approaches for global DNA methylation profiling. Trends Genet 24, 231-237 (2008).
2. Lu, Q. et al. Epigenetics, disease, and therapeutic interventions. Ageing research reviews 5, 449-467 (2006).
3. Zilberman, D. & Henikoff, S. Genome-wide analysis of DNA methylation patterns. Development 134, 3959-3965 (2007).
4. Feinberg, A.P. & Tycko, B. The history of cancer epigenetics. Nature reviews 4, 143-153 (2004).
5. Weber, M. et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39, 457-466 (2007).
6. Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37, 853-862 (2005).
7. Wilson, I.M. et al. Epigenomics: mapping the methylome. Cell Cycle 5, 155-158 (2006).
8. Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C.M. & Green, M.R. An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449, 1073-1077 (2007).
9. Karpinski, P., Sasiadek, M.M. & Blin, N. Aberrant epigenetic patterns in the etiology of gastrointestinal cancers. Journal of applied genetics 49, 1-10 (2008).
10. Maekawa, M. & Watanabe, Y. Epigenetics: relations to disease and laboratory findings. Current medicinal chemistry 14, 2642-2653 (2007).
11. Vucic, E.A., Brown, C.J. & Lam, W.L. Epigenetics of cancer progression. Pharmacogenomics 9, 215-234 (2008).
12. Egger, G., Liang, G., Aparicio, A. & Jones, P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429, 457-463 (2004).
13. Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3, 415-428 (2002).
14. Fraga, M.F. & Esteller, M. DNA methylation: a profile of methods and applications. Biotechniques 33, 632, 634, 636-649 (2002).